{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:48:41Z","timestamp":1779374921522,"version":"3.53.1"},"reference-count":96,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejmech.2025.118049","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:43:35Z","timestamp":1754635415000},"page":"118049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Design, synthesis, radiolabeling, and mechanistic insights of hydrazinyl imidazolones as broad spectrum antitumor agents with potential carbonic anhydrase inhibition: In vitro, in vivo, and in silico studies"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6594-1766","authenticated-orcid":false,"given":"Ebtehal M.","family":"Husseiny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa T.","family":"Sarg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin S.","family":"Sheta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal M.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-5534","authenticated-orcid":false,"given":"Fatma G.","family":"Abdulrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118049_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2025.118049_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.21037\/jtd.2017.02.75","article-title":"Cancer prevention from the perspective of global cancer burden patterns","volume":"9","author":"Nagai","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejmech.2025.118049_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3332\/ecancer.2019.961","article-title":"Innovative approaches for cancer treatment: current perspectives and new challenges","volume":"13","author":"Pucci","year":"2019","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.ejmech.2025.118049_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131285","article-title":"Design, synthesis, anticancer evaluation and molecular docking study of novel 2,4-dichlorophenoxymethyl-based derivatives linked to nitrogenous heterocyclic ring systems as potential CDK-2 inhibitors","volume":"1247","author":"El-Sayed","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41568-019-0209-6","article-title":"The pro-tumorigenic host response to cancer therapies","volume":"19","author":"Shaked","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118049_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136358","article-title":"Novel pyridine-thiazolidinone-triazole hybrid glycosides targeting EGFR and CDK-2: design, synthesis, anticancer evaluation, and molecular docking simulation","volume":"1294","author":"Kassem","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21608\/aijpms.2021.78337.1077","article-title":"Novel mnnich bases derived from 2-substituted benzimidazole and (thio)hydantoin moieties as potent histone deacetylase 6 (HDAC6) inhibitors","volume":"1","author":"Mansour","year":"2021","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.21608\/aijpms.2022.147229.1149","article-title":"Novel pyrido-thiazolo-pyrimidinone hybrids targeting EGFRWT and EGFRT790M: design, synthesis, anticancer activity and docking simulation","volume":"3","author":"Alasfoury","year":"2023","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21608\/aijpms.2024.220640.1222","article-title":"Synthesis, cytotoxicity assessment and molecular docking of novel thienyl-pyrazoles as VEGFR2 Inhibitors","volume":"4","author":"Amin","year":"2024","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm501573b","article-title":"Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties","volume":"58","author":"Bozta\u015f","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.17776\/csj.340483","article-title":"The effects of Oxytocin and Oxytocin receptor antagonist Atosiban on the carbonic anhydrase and acetylcholinesterase enzymes from lung tissues of rats","volume":"38","author":"Kocyigit","year":"2017","journal-title":"Cumhur. Sci. J."},{"key":"10.1016\/j.ejmech.2025.118049_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62864-9","article-title":"New sulfonamide-based glycosides incorporated 1,2,3-triazole as cytotoxic agents through VEGFR-2 and carbonic anhydrase inhibitory activity","volume":"14","author":"Abbas","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.118049_bib13","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/07391102.2020.1818623","article-title":"Phthalocyanine complexes with (4-isopropylbenzyl)oxy substituents: preparation and evaluation of anti-carbonic anhydrase, anticholinesterase enzymes and molecular docking studies","volume":"40","author":"G\u00fczel","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118049_bib14","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1080\/07391102.2020.1840440","article-title":"Biological effects and molecular docking studies of Catechin 5-O-gallate: antioxidant, anticholinergics, antiepileptic and antidiabetic potentials","volume":"40","author":"Taslimi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118049_bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/07391102.2020.1811772","article-title":"Design, synthesis, characterization, biological evaluation, and molecular docking studies of novel 1,2-aminopropanthiols substituted derivatives as selective carbonic anhydrase, acetylcholinesterase and \u03b1-glycosidase enzymes inhibitors","volume":"40","author":"Huseynova","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2025.118049_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100242","article-title":"Discovery of sulfadrug\u2013pyrrole conjugates as carbonic anhydrase and acetylcholinesterase inhibitors","volume":"355","author":"G\u00fcm\u00fc\u015f","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118049_bib17","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1021\/acsomega.1c06836","article-title":"New benzimidazole-, 1,2,4-triazole-, and 1,3,5-triazine-based derivatives as potential EGFR WT and EGFR T790M inhibitors: microwave-assisted synthesis, anticancer evaluation, and molecular docking study","volume":"7","author":"Hashem","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118049_bib18","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.3390\/molecules24132447","article-title":"Optimisation by design of experiment of benzimidazol-2-One synthesis under flow conditions","volume":"24","author":"Mostarda","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118049_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103102","article-title":"Synthesis, biological evaluation and in silico studies with 4-benzylidene-2-phenyl-5(4H)-imidazolone-based benzenesulfonamides as novel selective carbonic anhydrase IX inhibitors endowed with anticancer activity","volume":"90","author":"Eldehna","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cclet.2016.01.049","article-title":"Synthesis, antimicrobial and anti-inflammatory activities of some novel 5-substituted imidazolone analogs","volume":"27","author":"Dhingra","year":"2016","journal-title":"Chinese Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118049_bib21","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/molecules25122766","article-title":"Synthesis, antimicrobial activity and molecular docking of novel thiourea derivatives tagged with thiadiazole, imidazole and triazine moieties as potential DNA gyrase and topoisomerase IV Inhibitors","volume":"25","author":"Hashem","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118049_bib22","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.3390\/molecules171012262","article-title":"Design, synthesis and in vivo anti-inflammatory activities of 2,4-Diaryl-5-4H-imidazolone derivatives","volume":"17","author":"El-Araby","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118049_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1248\/cpb.c18-00398","article-title":"Design, synthesis and antiproliferative activities of oxidative stress inducers based on 2-styryl-3,5-dihydro-4H-imidazole-4-one scaffold","volume":"66","author":"Omar","year":"2018","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2025.118049_bib24","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1134\/S1070363218120277","article-title":"1,3,4-triarylpyrazoles containing 2-thioxoimidazolidinones and different fused systems: synthesis and antimicrobial activity","volume":"88","author":"Khalifa","year":"2018","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib25","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00044-013-0799-6","article-title":"Synthesis and pharmacological evaluation of novel 1-(piperidin-4-yl)-1H-benzo[d]imidazole-2(3H)-one derivatives as potential antimicrobial agents","volume":"23","author":"Patel","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118049_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5530\/ijper.54.3.129","article-title":"Novel quinolone substituted imidazole-5(4H)-ones as anti-inflammatory, anticancer agents: synthesis, biological screening and molecular docking studies","volume":"54","author":"Kumar","year":"2020","journal-title":"Indian J. Pharm. Educ. Res."},{"key":"10.1016\/j.ejmech.2025.118049_bib27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00280-006-0294-6","article-title":"MZ3 induces apoptosis in human leukemia cells","volume":"59","author":"Fang","year":"2006","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118049_bib28","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/01961779108048760","article-title":"Imidazole-2-thiones: synthesis, structure, properties","volume":"10","author":"Trzhtsinskaya","year":"1991","journal-title":"Sulfur Rep."},{"key":"10.1016\/j.ejmech.2025.118049_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bioorg.2019.01.014","article-title":"Synthesis, characterization, antioxidant power and acute toxicity of some new azo-benzamide and azo-imidazolone derivatives with in vivo and in vitro antimicrobial evaluation","volume":"85","author":"Samad","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bioorg.2018.09.037","article-title":"1,2,4-Trisubstituted imidazolinones with dual carbonic anhydrase and p38 mitogen-activated protein kinase inhibitory activity","volume":"82","author":"Georgey","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106872","article-title":"New imidazole-2-ones and their 2-thione analogues as anticancer agents and CAIX inhibitors: synthesis, in silico ADME and molecular modeling studies","volume":"141","author":"Ibrahim","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejmech.2012.10.011","article-title":"Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents","volume":"58","author":"Alt\u0131ntop","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21608\/aijpms.2023.176667.1180","article-title":"Discovery of new quinoxalines as cytotoxic agents: design, synthesis and molecular modeling","volume":"3","author":"Ibrahim","year":"2023","journal-title":"Azhar Int. J. Pharm. Med. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0223-5234(01)01326-5","article-title":"Synthesis, characterisation and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds","volume":"37","author":"K\u00fc\u00e7\u00fckg\u00fczel","year":"2002","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib35","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1021\/ol802065d","article-title":"Synthesis and antifungal activity of (\u2212)-(Z)-dysidazirine","volume":"10","author":"Skepper","year":"2008","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2025.118049_bib36","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.bmc.2007.06.006","article-title":"1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: synthesis, analgesic-anti-inflammatory and antimicrobial activities","volume":"15","author":"Salg\u0131n-G\u00f6k\u015fen","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103088","article-title":"Synthesis and anticancer activity of bis-benzo[d][1,3]dioxol-5-yl thiourea derivatives with molecular docking study","volume":"90","author":"Al-Harbi","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib38","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cclet.2012.06.009","article-title":"Design, synthesis and antiproliferative activities of diaryl urea derivatives bearing N-acylhydrazone moiety","volume":"23","author":"Zhang","year":"2012","journal-title":"Chinese Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118049_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133816","article-title":"Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular docking studies of new imidazolyl hydrazone derivatives","volume":"1269","author":"Tapera","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2019.06.081","article-title":"Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic\/phobic tails for targeting the middle region of human carbonic anhydrases active site: selective inhibitors of hCA IX","volume":"179","author":"Allam","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111768","article-title":"3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in vitro biological evaluation and in silico insights","volume":"184","author":"Abo-Ashour","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib42","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.bioorg.2018.07.027","article-title":"Synthesis of novel isoindoline-1,3-dione-based oximes and benzenesulfonamide hydrazones as selective inhibitors of the tumor-associated carbonic anhydrase IX","volume":"80","author":"Abdel-Aziz","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114190","article-title":"Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach","volume":"232","author":"Tawfik","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105762","article-title":"Apoptosis induction, PARP-1 inhibition, and cell cycle analysis of leukemia cancer cells treated with novel synthetic 1,2,3-triazole-chalcone conjugates","volume":"123","author":"Othman","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106397","article-title":"Exploring the cytotoxic effect and CDK-9 inhibition potential of novel sulfaguanidine-based azopyrazolidine-3,5-diones and 3,5-diaminoazopyrazoles","volume":"133","author":"Husseiny","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106789","article-title":"Molecular overlay-guided design of new CDK2 inhibitor thiazepinopurines: synthesis, anticancer, and mechanistic investigations","volume":"140","author":"Husseiny","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4155\/fmc-2023-0198","article-title":"Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations","volume":"16","author":"Abdulrahman","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107105","article-title":"Design, synthesis, and mechanistic insight of novel imidazolones as potential EGFR inhibitors and apoptosis inducers","volume":"144","author":"Abdulrahman","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.108106","article-title":"Exploring 1,2,3-triazole-schiff\u2019s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: in vitro and in silico study","volume":"155","author":"Nawareg","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib50","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1080\/17568919.2024.2419363","article-title":"In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties","volume":"16","author":"Husseiny","year":"2024","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib51","first-page":"1097","article-title":"2-Thiohydantoin derivatives in the synthesis of some condensed heterocyclic compounds with expected biological activity","volume":"9","author":"Hassan","year":"2012","journal-title":"Life Sci. J."},{"key":"10.1016\/j.ejmech.2025.118049_bib52","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1570180816666181212153011","article-title":"Synthesis and antimicrobial activity of thiohydantoins obtained from L-amino acids","volume":"17","author":"de Carvalho","year":"2018","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.ejmech.2025.118049_bib53","first-page":"3649","article-title":"Thiohydantoins: selective N- and S-functionalization for liebeskind-srogl reaction study","volume":"22","author":"Gosling","year":"2011","journal-title":"Synthesis (Stuttg)."},{"key":"10.1016\/j.ejmech.2025.118049_bib54","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/adsc.202000134","article-title":"Sulfenyl ynamides in gold catalysis: synthesis of oxo-functionalised 4-aminoimidazolyl fused compounds by intermolecular annulation reactions","volume":"362","author":"Arce","year":"2020","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2025.118049_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107471","article-title":"Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: design, synthesis, cytotoxicity evaluation, and mechanistic insights","volume":"149","author":"Sheta","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib56","first-page":"529","article-title":"A novel synthesis of some new imidazothiazole and glycocyamidine derivatives and studies on their antimicrobial activities, Phosphorus, Sulfur Silicon Relat","volume":"182","author":"Magd El-Din","year":"2007","journal-title":"Elem."},{"key":"10.1016\/j.ejmech.2025.118049_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3184\/174751916X14499306304628","article-title":"Synthesis of novel derivatives of imidazo[2,1-c][1,2,4]triazine from biologically active 4-arylidene-2-hydrazino-1-phenyl-1H-imidazole-5(4H)-ones and evaluation of their antimicrobial activity","volume":"40","author":"El-Aal","year":"2016","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.ejmech.2025.118049_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/jhet.3370","article-title":"Convenient synthesis of novel nitrogen bridgehead heterocycles utilizing 3-mercapto-6H-[1,2,4,5]oxatriazino[3,2-a]isoindol-6-one as a new synthon","volume":"56","author":"El Azab","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib59","first-page":"1157","article-title":"A convenient preparation of 2-(2-arylidene)- and 2-(2-polyhydroxyalkylidene)hydrazono-4-imidazolidinones with various heterocyclic side chain substituents at position 5 as potential antiviral and antitumor agents, Phosphorus, Sulfur Silicon Relat","volume":"177","author":"Khodair","year":"2002","journal-title":"Elem."},{"key":"10.1016\/j.ejmech.2025.118049_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2020.129865","article-title":"Potential antiviral and anticancer effect of imidazoles and bridgehead imidazoles generated by HPV-Induced cervical carcinomas via reactivating the P53\/pRb pathway and inhibition of CA IX","volume":"1230","author":"Hassan","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib61","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.biopha.2018.04.163","article-title":"New hydrazide-hydrazones and 1,3-thiazolidin-4-ones with 3-hydroxy-2-naphthoic moiety: synthesis, in vitro and in vivo studies","volume":"103","author":"Popio\u0142ek","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118049_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131398","article-title":"Anticholinesterase activities of novel indole-based hydrazide-hydrazone derivatives: design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction","volume":"1247","author":"Co\u015far","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133817","article-title":"A new thiazoldinone and triazole derivatives: synthesis, characterization and liquid crystalline properties","volume":"1270","author":"Tomma","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib64","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/jhet.3930","article-title":"Synthesis and in vitro anticancer activity of some novel tetrahydroquinoline derivatives bearing pyrazol and hydrazide moiety","volume":"57","author":"Fathy","year":"2020","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.132797","article-title":"Design, synthesis and anticancer activity studies of novel 4-butylaminophenyl hydrazide-hydrazones as apoptotic inducers","volume":"115","author":"Han","year":"2022","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2025.118049_bib66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2016.07.005","article-title":"Synthesis and in vitro acetylcholinesterase and butyrylcholinesterase inhibitory potential of hydrazide based Schiff bases","volume":"68","author":"Rahim","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib67","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bmc.2019.02.002","article-title":"Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives","volume":"27","author":"Sreenivasulu","year":"2019","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115270","article-title":"Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B\/AKR1B1 inhibitors","volume":"252","author":"Maccari","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140672","article-title":"Synthesis, crystal structures, DFT calculations, and oxygen radical absorbance capacity of 5-arylidene-thiazolidine-2,4-dione derivatives","volume":"1323","author":"Boudebbous","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118049_bib70","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jnci\/83.11.757","article-title":"Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines","volume":"83","author":"Monks","year":"1991","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejmech.2025.118049_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107596","article-title":"Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"150","author":"Liang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189120","article-title":"Carbonic anhydrase IX: an atypical target for innovative therapies in cancer","volume":"1879","author":"Ronca","year":"2024","journal-title":"Biochim. Biophys. Acta - Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.118049_bib73","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jconrel.2025.02.032","article-title":"In vivo MRI of breast cancer using carbonic anhydrase IX proteoglycan-like domain -targeting liposomes","volume":"380","author":"Quattrociocchi","year":"2025","journal-title":"J. Control. Release."},{"key":"10.1016\/j.ejmech.2025.118049_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2025.136124","article-title":"Targeted cancer cell supramolecular nanoparticles self-assembled from acyclic cucurbit[n]urils for combined chemo\/chemodynamic\/photothermal therapy","volume":"709","author":"Li","year":"2025","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ejmech.2025.118049_bib75","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2018.12.049","article-title":"Continued exploration of 1,2,4-oxadiazole periphery for carbonic anhydrase-targeting primary arene sulfonamides: discovery of subnanomolar inhibitors of membrane-bound hCA IX isoform that selectively kill cancer cells in hypoxic environment","volume":"164","author":"Krasavin","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113490","article-title":"Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold","volume":"220","author":"Salerno","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib77","first-page":"355","article-title":"Design, synthesis, and biological activity of novel dithiocarbamate-methylsulfonyl hybrids as carbonic anhydrase inhibitors","author":"Osmaniye","year":"2022","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.ejmech.2025.118049_bib78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.ejmech.2025.118049_bib79","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2025.118049_bib80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis flow cytometric detection of phosphatidylserine early apoptotic cells using fluorescein labelled expression on Annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejmech.2025.118049_bib81","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ejmech.2017.04.069","article-title":"Design, synthesis and biological evaluation of some novel sulfonamide derivatives as apoptosis inducers","volume":"135","author":"Mohamed","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib82","doi-asserted-by":"crossref","first-page":"36989","DOI":"10.1039\/D1RA06799K","article-title":"New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies","volume":"11","author":"Syam","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2025.118049_bib83","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/ph12010025","article-title":"Comparative study of two oxidizing agents, chloramine T and Iodo-Gen\u00ae, for the radiolabeling of \u03b2-CIT with iodine-131: relevance for Parkinson's disease","volume":"12","author":"Durante","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118049_bib84","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1107\/S1744309109036665","article-title":"High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design","volume":"65","author":"Sippel","year":"2009","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.ejmech.2025.118049_bib85","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1039\/c3cc39205h","article-title":"Quantitative comparison of protein dynamics in live cells and in vitro by in-cell19F-NMR","volume":"49","author":"Takaoka","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2025.118049_bib86","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib87","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2025.118049_bib88","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","article-title":"Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen","volume":"34","author":"Boyd","year":"1995","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.ejmech.2025.118049_bib89","doi-asserted-by":"crossref","first-page":"12206","DOI":"10.1039\/D2NJ02061K","article-title":"Rationale design, synthesis, cytotoxicity evaluation, and in silico mechanistic studies of novel 1,2,3-triazoles with potential anticancer activity","volume":"46","author":"Othman","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib90","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.4155\/fmc-2023-0139","article-title":"Aminopyridone-linked benzimidazoles: a fragment-based drug design for the development of CDK9 inhibitors","volume":"15","author":"Husseiny","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105968","article-title":"The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia","volume":"127","author":"Othman","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib92","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1016\/j.bmc.2014.05.009","article-title":"Carbonic anhydrase inhibitors: synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties","volume":"22","author":"Ghorab","year":"2014","journal-title":"Bioorganic Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib93","doi-asserted-by":"crossref","first-page":"28.6.1","DOI":"10.1002\/0471142727.mb2806s111","article-title":"Assaying cell cycle status using flow cytometry","volume":"111","author":"Kim","year":"2015","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118049_bib94","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1039\/D3NJ01638B","article-title":"Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer","volume":"47","author":"Ismail","year":"2023","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2025.118049_bib95","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijpharm.2017.06.044","article-title":"Comparative study on radiolabeling and biodistribution of core-shell silver\/polymeric nanoparticles-based theranostics for tumor targeting","volume":"529","author":"Farrag","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2025.118049_bib96","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10967-020-07236-z","article-title":"Optimization and tissue distribution of [125I]iododomperidone as a radiotracer for D2-receptor imaging","volume":"325","author":"Khater","year":"2020","journal-title":"J. Radioanal. Nucl. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:53:32Z","timestamp":1769622812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":96,"alternative-id":["S0223523425008141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118049","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, radiolabeling, and mechanistic insights of hydrazinyl imidazolones as broad spectrum antitumor agents with potential carbonic anhydrase inhibition: In vitro, in vivo, and in silico studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118049"}}